Evidence map›Paper›PMID 30907889›Full record

ArticleJournal of visualized experiments : JoVE2019

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats.

Michael G Katz, Anthony S Fargnoli, Sarah M Gubara, Malik Bisserier, Yassine Sassi, Charles R Bridges, Roger J Hajjar, Lahouaria Hadri

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Pulmonary hypertension associated with nonparenchymal restrictive lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  4. Review
  5. Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Pericytes: The lung-forgotten cell type.Frontiers in physiology · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Michael G KatzCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Anthony S FargnoliCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Sarah M GubaraCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Malik BisserierCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Yassine SassiCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Charles R BridgesCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Roger J HajjarCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai.
Lahouaria HadriCardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai; lahouaria.hadri@mssm.edu.
Icahn School of Medicine at Mount Sinai · USCardiovascular Research Center · BR

Funding

Translational Studies in Heart Failure Gene TherapyR01HL083078 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BRIDGES, CHARLES R · 2007 to 2018
$9.2M
TRAINING PROGRAM IN MOLECULAR AND CELLULAR CARDIOLOGYT32HL007824 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GELB, BRUCE D · 1995 to 2022
$8.6M
Interactions of SERCA2a and BMPRII in Vascular DiseaseR01HL133554 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HADRI, LAHOUARIA · 2016 to 2020
$2.3M
The role of extracellular cAMP in the pathogenesis of pulmonary arterial hypertensionK01HL135474 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SASSI, YASSINE · 2018 to 2022
$853k
NHLBI NIH HHS K01 HL135474NHLBI NIH HHS R01 HL083078NHLBI NIH HHS R01 HL133554NHLBI NIH HHS T32 HL007824
6 · The paper itself

Abstract

In this protocol, we detail the correct procedural steps and necessary precautions to successfully perform a left pneumonectomy and induce PAH in rats with the additional administration of monocrotaline (MCT) or SU5416 (Sugen). We also compare these two models to other PAH models commonly used in research. In the last few years, the focus of animal PAH models has moved towards studying the mechanism of angioproliferation of plexiform lesions, in which the role of increased pulmonary blood flow is considered as an important trigger in the development of severe pulmonary vascular remodeling. One of the most promising rodent models of increased pulmonary flow is the unilateral left pneumonectomy combined with a "second hit" of MCT or Sugen. The removal of the left lung leads to increased and turbulent pulmonary blood flow and vascular remodeling. Currently, there is no detailed procedure of the pneumonectomy surgery in rats. This article details a step-by-step protocol of the pneumonectomy surgical procedure and post-operative care in male Sprague-Dawley rats. Briefly, the animal is anesthetized and the chest is opened. Once the left pulmonary artery, pulmonary vein, and bronchus are visualized, they are ligated and the left lung is removed. The chest then closed and the animal recovered. Blood is forced to circulate only on the right lung. This increased vascular pressure leads to a progressive remodeling and occlusion of small pulmonary arteries. The second hit of MCT or Sugen is used one week post-surgery to induce endothelial dysfunction. The combination of increased blood flow in the lung and endothelial dysfunction produces severe PAH. The primary limitation of this procedure is that it requires general surgical skills.

Indexed as

PneumonectomyAnimalsDisease Models, AnimalHypertension, PulmonaryIndolesLungMaleMonocrotalinePulmonary ArteryPyrrolesRats, Sprague-DawleyIndolesMonocrotalinePyrrolesSemaxinib

Identifiers

PMID30907889
PMCPMC7992111
OpenAlexW2922150089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.